Cerbios-Pharma brings innovative HPAI and ADC solutions to San Francisco events


Cerbios-Pharma brings innovative HPAI and ADC solutions to San Francisco events


Cerbios Logo

Press Release | Cerbios-Pharma SA

DECEMBER 23, 2016

Lugano, Switzerland: – Cerbios-Pharma SA (Cerbios), the Swiss-based specialist in high-potency active pharmaceutical ingredients (HPAIs) and antibody-drug conjugates (ADCs) will make its first attendance at two key events in San Francisco in January.

Cerbios will be present throughout the Biotech Showcase partnering conference, January 9-11th 2017, in San Francisco, in company with its ADC Alliance partners: CMC, IDT and Oncotec. This will be followed by presence at the 35th Annual J.P Morgan Healthcare Conference, which runs till January 13th.

Together, the two events form a red-letter week for the North American life sciences industry, bringing thousands of investors and executives from around the world to San Francisco to hear companies present their latest innovations and business opportunities.

One-stop ADC solution

Cerbios will take advantage of the events to discuss its innovative technologies for developing and producing chemical and biological HPAIs and ADCs.

Cerbios recently co-founded the PROVEO™ consortium with CMC Biologics of Denmark, together with Germany’s Oncotec and IDT Biologika to offer a one stop shop service from substance development all the way through to full finish.

Cerbios CEO Dr. Gabriel Haering and Business Development Manager Mr. Simone Sala will represent that company in San Francisco, with a dedicated suite at the downtown Parc 55 Hotel available for meetings.

Cerbios will be pleased to schedule face-to-face meetings ahead of the event on request (see Contact details below).

About Cerbios-Pharma

Cerbios-Pharma SA is a privately held company located in Lugano, Switzerland, that specializes in the development and manufacture of both chemical and biological APIs for its partners world-wide. Cerbios specializes in the development and production of high potency active pharmaceutical ingredients (HPAPIs) in the area of fine chemicals and biologicals.

Cerbios Chemical Division offers exclusive, third party manufacturing services for HPAIs while Biological Division produces monoclonal antibodies, recombinant proteins and pharma probiotics.

Cerbios provides full CMC support to its worldwide partners, including the supply of cGMP clinical batches, registration/validation material and commercially manufactured APIs. Paramount to this is the ability to supply all of the technical documentation and support necessary for a successful registration. Cerbios’ commercial products are marketed worldwide but primarily in Europe, USA, Japan and India.

About Biotech Showcase & J.P. Morgan Healthcare

Biotech Showcase is an internationally renowned and well-established North American investor conference providing life science companies with high caliber partnering opportunities, similar to its sister conference BIO-Europe.

Now in its ninth year, Biotech Showcase 2017 is expected to attract more than 2,800 delegates representing some 1,600 companies from 40 countries.

Biotech Showcase 2017 is a three-day event opening January 9 at the Hilton Hotel in San Francisco’s Union Square.

Partnering and networking is constructed around a multi-faceted programme of plenary and breakout events and presentations, aided by EBD Group’s partneringONE®, the industry’s most advanced networking system, which enables participants to efficiently mine a large pool of potential partners, and identify and pre-arrange private one-to-one meetings with multiple company targets.

The event is organized by EBD with more information at: www.ebdgroup.knect365.com/biotech-showcase/

The event coincides with the 35th Annual J.P Morgan Healthcare Conference, which also opens January 9 and runs through to January 13 at San Francisco’s Westin St. Francis Hotel. The investment bank’s conference is one of the life science industry’s largest partnering events of the year, attracting thousands of C-suite investors and executives from around the world to hear companies present their latest innovations.

Media Contact

Mr. Simone Sala, BD Manager, Cerbios-Pharma SA
Email: simone.sala@cerbios.ch

To set up meetings, please contact Commercial Operations Assistant Manager Chiara Brusadelli at: chiara.brusadelli@cerbios.ch

Resources

Click on Cerbios-Pharma brings innovative HPAI and ADC solutions to San Francisco events for more information.
Click on Cerbios-Pharma to contact the company directly.


Supplier Information
Supplier: Cerbios-Pharma SA
Address: Via Figino 6, 6917 Barbengo/Lugano Switzerland
Tel: +41 (0) 919856311
Fax: +41 (0) 919856325
Website: www.cerbios.ch


Comments are closed.